Epsilon M&A Deal Report - Lessonia
Transaction Multiples for the Valuation of Private Companies
Private Group backed by Bpifrance, NewAlpha Verto Capital and BNP Paribas Development / Lessonia
No EMAT :
112641
Announced Date :
14/03/2023
Type :
MBO (Management Buy Out)
Deal Value :
Yes
Acquirer :
Private Group backed by Bpifrance, NewAlpha Verto Capital and BNP Paribas Development
Target :
Lessonia
Country :
Finistère
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Personal Products
Business Description :
Founded in 2002 by Christophe Winckler, Lessonia develops and manufactures ingredients and customized cosmetic products for third parties. > Activities: Cosmetics Ingredients Fodd. > Historically...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|||||
| Current |
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Personal Products » = 127
| Date | Acquirer | Target | Country | Multiples | See details |
| 18/02/2020 | B2A (Biola) | Biolix | France | ** | 112613 |
| 24/04/2023 | Private Group backed by Vivalto Partners | Laboratoires Delbert | France | * | 112600 |
Source: Epsilon Research / EMAT
